NexImmune (NEXI) SEC Filings & 10K Form

$3.49
+0.08 (+2.35%)
(As of 05/14/2024 ET)

Recent NexImmune SEC Filings

DateFilerForm TypeView
04/10/2024
4:13 PM
Marchio Albert N II (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2024
3:30 PM
NexImmune (Filer)
Form DEFA14A
02/05/2024
4:10 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:34 PM
NexImmune (Filer)
Form 424B5
02/02/2024
12:25 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
8:17 AM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:43 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
3:43 PM
NexImmune (Filer)
Form DEFA14A
12/22/2023
3:01 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
12:39 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
4:40 PM
NexImmune (Subject)
Roemer Alan S. (Reporting)
Form 144/A
11/22/2023
4:34 PM
NexImmune (Subject)
Roemer Alan S. (Reporting)
Form 144/A
11/22/2023
4:18 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:39 PM
NexImmune (Subject)
Roemer Alan S. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
4:19 PM
NexImmune (Filer)
Form DEF 14A
11/09/2023
4:47 PM
NexImmune (Filer)
Form PRE 14A
11/02/2023
4:12 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:33 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
3:15 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:42 PM
NexImmune (Filer)
Form DEF 14A
09/15/2023
3:06 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
4:14 PM
NexImmune (Filer)
Form PRE 14A
09/08/2023
6:23 PM
NexImmune (Issuer)
STOVER TIMOTHY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/07/2023
3:20 PM
NexImmune (Issuer)
Yao Zhengbin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:21 PM
Gandhi Leena (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:24 PM
NexImmune (Issuer)
Verstandig Grant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:16 PM
Bertram Timothy (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:16 PM
D'Angio Paul (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:16 PM
BARER SOL J (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:17 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
7:37 AM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
3:03 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NEXI) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners